Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Heva Health vs Hims & Hers

Heva Health
Graded #114

Lower grade

vs+11.299999999999997
Hims & Hers
Graded #36

Higher grade

The verdict

Hims & Hers takes it — 81/100 to 69.7/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHims & Hers +8
74
82
Dose & formulationHims & Hers +26
52
78
Clinical oversightHims & Hers +8
74
82
Labs & monitoringHeva Health +9
89
80
FulfillmentHims & Hers +15
69
84
Contract termsHims & Hers +25
55
80
Heva Health · left barHims & Hers · right bar

The numbers

MetricHeva HealthHims & Hers
WeighScore69.7/10081/100
GradeCB−
Scorecard rank#114#36
Semaglutide$149/mo (compounded)$199/mo
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Heva Health

Graded #114 · C

Strengths

  • $149/mo entry pricing for compounded GLP-1 is competitive
  • LegitScript Certified
  • Claims licensure in all 50 states
  • Comprehensive 91-biomarker lab panel bundled — a differentiator vs compounded-GLP-1-only peers
  • Concierge care plus HRT/TRT alongside GLP-1 for an integrated longevity stack

Where it loses points

  • Tirzepatide pricing not shown — only the generic $149/mo weight-loss entry
  • Legal entity name and state of incorporation not disclosed
  • Partner pharmacy not named
  • Per-state availability not listed despite the all-50-states claim
  • Brand-name GLP-1 options (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) not addressed
Hims & Hers

Graded #36 · B−

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard